PharmaBioSource
PharmaBioSource is a privately held life sciences advisory firm providing transaction, consulting, and diligence services to global biopharmaceutical companies, CDMOs, and PE/VC investors, having completed over 100 deals valued above $5 billion since 1999.
- Company typePrivate
- Founded1999
- HeadquartersWayne, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PharmaBioSource does
PharmaBioSource is a privately held, Pennsylvania-based life sciences advisory and consulting firm founded in 1999 by William (Bill) B. Wiederseim. The firm delivers transaction, consulting, and diligence services to global biopharmaceutical companies, pharmaceutical service providers (CDMOs/CMOs), and private equity/venture capital investors across the life sciences sector. Over 25 years of operation, the firm has completed more than 100 transactions in therapeutic assets, pharmaceutical facilities, and companies with a cumulative value exceeding US$5 billion, supported by a multinational team with presence on three continents.
The firm's core offerings are organized into three service lines. Transaction Services covers buy-side advisory, sell-side advisory, in/out-licensing transactions, and specialized life sciences real estate services delivered through subsidiary PharmaBioSource Realty, LLC. Consulting encompasses Build/Buy/Outsource analysis, market opportunity analysis, private equity consulting for life sciences, and manufacturing capacity evaluation for biotech. Diligence provides investment evaluation, supply chain risk assessment, technical performance review, logistics analysis, and regulatory compliance risk analysis. The firm's competitive differentiation rests on a partner-level team drawn from senior operating roles at Pfizer (multiple partners, including Charles Shafran with 37 years), Merck, Wyeth, GlaxoSmithKline, Pharmacia, and other major manufacturers.
PharmaBioSource operates a pure professional services model with project-based, quote-driven engagements and no technology product, no subscription pricing, and no recurring SaaS revenue. Go-to-market is relationship-driven: senior consultants and partners engage directly with enterprise clients, sourced through 25 years of industry network and repeat mandates from buyers, sellers, and PE sponsors. The firm is privately held with no external funding, no parent company, and no public financials. Notable customers include Reckitt Benckiser, Pfizer, Merck, Eisai, Shire, Baxalta/Takeda, Indivior, Petrichor Healthcare Capital Management, and Youcare Pharmaceutical Group.
PharmaBioSource firmographics
Firmographics- Name
- PharmaBioSource
- Legal name
- PharmaBioSource, Inc.
- Website
- https://pharmabiosource.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PharmaBioSource is a privately held life sciences advisory firm providing transaction, consulting, and diligence services to global biopharmaceutical companies, CDMOs, and PE/VC investors, having completed over 100 deals valued above $5 billion since 1999.
- Ownership category
- akta.pro rank
Where PharmaBioSource is headquartered
LocationHeadquarters
- HQ city
- Wayne
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
PharmaBioSource business model
Business model- GTM type
- B2B
- Offering type
- Services
Revenue model
- Consulting Services: Professional consulting fees for advisory services including transaction support, due diligence, market analysis, and strategic consulting for life sciences companies and investors.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
PharmaBioSource product offering
Product offeringCore offering
PharmaBioSource is a global life sciences consulting firm providing transaction advisory, strategic consulting, and due diligence services for biopharmaceutical companies, service providers, and investors. The firm helps clients transact on life science businesses, pharmaceutical facilities, and therapeutic assets worldwide through buy-side advisory, sell-side advisory, licensing transactions, life sciences real estate, and investment diligence support.
Product overview
PharmaBioSource is a global life sciences consulting firm offering a unified advisory platform centered on transaction services, consulting, and diligence. The core Transaction Services module encompasses buy-side advisory, sell-side advisory, licensing transactions, and life sciences real estate services. The Consulting module provides specialized capabilities including Build/Buy/Outsource analysis, Market Opportunity Analysis, Private Equity Consulting, and Manufacturing Capacity Evaluation. The Diligence module offers comprehensive due diligence services. These offerings are designed to work together, enabling clients to navigate the entire lifecycle of life science transactions from opportunity identification through closing.
Differentiator
Problem solved
Functional benefit
Products and services
- Transaction Services End-to-end life science transaction services including buy-side advisory, sell-side advisory, licensing transactions, and life sciences real estate transactions for pharmaceutical facilities, companies, and therapeutic assets.
- Pharmaceutical Manufacturing Consulting Advisory services for pharmaceutical manufacturing decisions including build/buy/outsource analysis, market opportunity analysis, private equity consulting, and manufacturing capacity evaluation.
- Pharma Investment Diligence Due diligence services covering investment evaluation, supply chain risk assessment, technical performance review, logistics analysis, and regulatory compliance risk analysis for life sciences transactions.
Quantifiable outcome
- Over 100+ successful transactions in therapeutic assets and pharmaceutical facilities
- +3 more outcomes
Companies that use PharmaBioSource
Customer profileNamed customers12 records
Segments6 records
Ideal customer profiles3 records
PharmaBioSource technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PharmaBioSource partnerships and signals
Strategic signalScale indicators5 records
Recent moves1 record
Expansion highlights5 records
PharmaBioSource competitors and assessment
Company assessmentBroad incumbents
- Bain & Company: Global management consulting firm with a leading Healthcare and Life Sciences practice serving pharma, biotech, and medtech clients on M&A, strategy, and operations. A much larger incumbent that competes for pharma M&A advisory mandates; relevant peer at the high end of the same market.
- ZS Associates: Global management consulting and technology firm with a large healthcare practice serving pharma, biotech, and medtech clients on commercial strategy, M&A, and operations. Larger and more technology-enabled than PharmaBioSource, but comparable in pharma M&A advisory and strategic consulting.
- Syneos Health Consulting: Biopharmaceutical services organization with a consulting arm providing commercial, M&A, and R&D strategy to pharma and biotech. Adjacent to PharmaBioSource in biopharma strategy and transaction advisory, though broader in clinical and commercial services.
- L.E.K. Consulting: Global management consulting firm with a deep life sciences practice covering pharma, biotech, and medtech M&A, commercial strategy, and operations. Larger and more diversified than PharmaBioSource, but directly comparable in pharma/biotech transaction advisory and strategic consulting.
- Charles River Associates: Global consulting firm with a Life Sciences practice providing strategy, M&A, and litigation support to pharma, biotech, and medical products companies. Comparable to PharmaBioSource in life sciences M&A advisory, transaction due diligence, and strategic consulting.
- Trinity Life Sciences: Large life sciences strategic consulting firm offering commercial strategy, M&A advisory, and evidence-based consulting to pharma and biotech. Broader and more commercial-focused than PharmaBioSource, but overlapping in life sciences strategy and M&A advisory.
Direct peers
- Locust Walk: Global life sciences transaction advisory firm providing M&A, capital markets, and strategic advisory services to biopharma and medtech companies. Comparable to PharmaBioSource in cross-border life sciences deal advisory, therapeutic asset transactions, and licensing support.
- Back Bay Life Science Advisors: Boston-based boutique advisory firm focused on life sciences transactions, capital raising, and strategic advisory for emerging and established biotech, medtech, and digital health companies. Direct peer in life sciences M&A advisory and licensing transactions.
- ClearView Healthcare Partners: New York and Boston-based life sciences consulting firm providing strategy, M&A, and commercial advisory to pharma, biotech, and medtech clients. Comparable to PharmaBioSource in life sciences strategic consulting, M&A advisory, and therapeutic asset diligence.
- Health Advances: Boston-based life sciences strategy consulting firm providing M&A, commercial strategy, and technology assessment to pharma, biotech, and medtech clients. Highly comparable to PharmaBioSource in life sciences M&A advisory, therapeutic asset transactions, and strategic consulting for biopharma companies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
PharmaBioSource social profiles
Digital presencePharmaBioSource financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaBioSource leadership team
Management profileNumber of profiles
Profiles15 records
PharmaBioSource subsidiaries and ownership
Company hierarchySubsidiaries1 record
PharmaBioSource funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaBioSource M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaBioSource
What does PharmaBioSource do?
PharmaBioSource is a global life sciences consulting firm providing transaction advisory, strategic consulting, and due diligence services for biopharmaceutical companies, service providers, and investors. The firm helps clients transact on life science businesses, pharmaceutical facilities, and therapeutic assets worldwide through buy-side advisory, sell-side advisory, licensing transactions, life sciences real estate, and investment diligence support.
Is PharmaBioSource a public or private company?
PharmaBioSource is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharmaBioSource founded?
PharmaBioSource was founded in 1999. It employs 11 to 50 people.
Where is PharmaBioSource based?
PharmaBioSource is headquartered in Wayne, United States, in the North America region.
How does PharmaBioSource make money?
One revenue line is on record: consulting Services.
Who are PharmaBioSource's main competitors?
Broad incumbents on record are Bain & Company, ZS Associates, Syneos Health Consulting, L.E.K. Consulting, Charles River Associates and Trinity Life Sciences. Direct peers are Locust Walk, Back Bay Life Science Advisors, ClearView Healthcare Partners and Health Advances.
Does PharmaBioSource have an API?
No public API is recorded for PharmaBioSource.